The Blueberry Recall Just Got More Serious—Here's What To Know
Back in early June, a recall was issued by Georgia-based company Alma Pak International LLC for hundreds of boxes of organic blueberries. As stated by the initial report, the recall came to be when, during routine testing, the product tested positive for Listeria monocytogenes. In total, 400 30-pound boxes were part of this recall, identifiable by Lot numbers 13325 G1060 and 13325 G1096. The voluntary recall stated that these products were shipped to one customer in North Carolina.
Though it was on June 9 that this recall was first issued, on July 1, the FDA elevated this situation to a Class I threat. As stated by their website, a Class I recall is 'a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.' While there have yet to be any reports of people falling ill after consuming this particular recalled product, vigilance is key when it comes to food safety.
Over the last year, listeria is the word that's been circulating when it comes to recalls, and the symptoms can range from mild to severe. According to the FDA's website, the less severe version of the illness is non-invasive and usually will result in side effects like nausea, vomiting, fever, aches and diarrhea. On the contrary, the invasive version can be fatal. 'Symptoms may include headache, stiff neck, confusion, loss of balance, and convulsions,' says the FDA website. 'Invasive listeriosis is a potentially life-threatening event, especially for newborns, adults over the age of 65, and those with weakened immune systems.'
If you think you might have consumed contaminated food, it's best to see your healthcare provider and monitor symptoms. If you start to feel any of the symptoms listed above, seek medical guidance.
In a statement to Newsweek, the company revealed that the recall was issued before blueberries even hit shelves, meaning no customers consumed these contaminated products, and therefore, no one was at risk. They continued, 'The company worked in close coordination with the U.S. Food and Drug Administration (FDA), the Georgia Department of Agriculture, and an independent food safety consultant to conduct a thorough investigation. Alma Pak International has implemented additional corrective actions and preventive controls to further strengthen its already rigorous food safety systems.'
Looking for more trending stories? Click through below!
Could '1969' Be the Next 'Yellowstone' Series? Rumors Fly About a Prequel Between '1944' and Today
From Tax Breaks to Medicaid Cuts: What the 'Big Beautiful Bill' Means for Americans 50+
Paula Deen's 5 Favorite Fourth of July Recipes—Drinks, Desserts & Deviled Eggs, Oh My! (EXCLUSIVE)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Piper Sandler Reaffirms Buy on Amgen Amid MariTide Tolerability Update
Amgen Inc. (NASDAQ:AMGN) ranks among the best set-it-and-forget-it stocks to buy. On June 24, Piper Sandler reaffirmed its Overweight rating and $328 price target for Amgen Inc. (NASDAQ:AMGN) in response to the company's disclosure of comprehensive MariTide tolerability data. 360b / The obesity medication's gastrointestinal tolerability profile unnerved the market, particularly the frequency of nausea and vomiting, which at first seemed more problematic than alternatives. Piper Sandler's study however, shows that both one- and two-step dose escalation regimens showed a noticeable improvement in the drug's tolerability profile, consistent with management's claims at the December top-line results announcement. According to the firm, the weight loss drug could produce a more commercially acceptable nausea and vomiting profile due to the much lower starting dosages and three-step dose escalation protocols included in the pivotal studies. Amgen Inc. (NASDAQ:AMGN) is a global biopharmaceutical company that focuses on human treatments for cardiovascular, hematology, inflammation, cancer, and bone health. While we acknowledge the potential of AMGN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤

Vogue
25 minutes ago
- Vogue
Is It Ever Possible to Tan Responsibly?
Hold up—is tanning making a comeback? Robert F. Kennedy, the Secretary of the United States Department of Health and Human Services and leader of the Make America Healthy Again movement, was recently spotted leaving a Washington, D.C. tanning salon Palm Beach Tan. A representative pleaded the fifth, however, on whether Kennedy was there for a spray tan, 20 minutes in the bed with deep dark intensifyer, or on official government business. And a new form of blush, which mimics a sunburn across the nose, is trending, while the models at Chloé's SS25 show were sporting tan lines. That's all on top of the SPF skepticism era we're currently living in: influencers are touting homemade sun protection that has no scientific backing, and skin cancer—an incredibly preventable cancer when preventative measures are taken—has become endemic. Truly, what gives? Board-certified dermatologist Anetta Reszko, MD, gets it. 'I grew up during a time when tanning was completely normalized and, in many ways, encouraged,' she confesses to Vogue. 'I didn't fully understand the long-term consequences of UV exposure until later in my medical training.' For those who are full-blown MAHA, the fact that almost half of Americans are deficient in vitamin D, also known as the 'sunshine vitamin,' may have something to do with it, too. 'There's also a growing appreciation for the psychological and biological benefits of sun exposure—from mood elevation and circadian rhythm support to vitamin D synthesis,' Dr. Resko adds. 'This all influences everything from immune resilience to metabolic health. In that context, sunlight is being reframed as an essential, healing force—part of a broader 'back to basics' wellness trend.' It's not about being anti-sun, it's about being anti-skin cancer. So safety is key—and in fact, there are ways to tan safely. 'The risk of tanning is not equal among everyone,' Manhattan-based board-certified dermatologist Elyse M. Love, MD, says. 'When it comes to skin cancer, the most important thing is to avoid burning. The second most important thing is to decrease cumulative sun exposure.' Dr. Resko agrees. 'You can enjoy the sun and protect your skin. Healthy skin isn't about extremes—it's about consistency and informed choices.'
Yahoo
42 minutes ago
- Yahoo
Why UnitedHealth Stock Is Sinking Again Today
UnitedHealth Group shares are sliding today following negative industry news from rival insurer Centene. Centene was forced to pull its full-year guidance due to troubling data. The company is facing major issues, including a DOJ fraud investigation and reports of significant misconduct. 10 stocks we like better than UnitedHealth Group › Shares of UnitedHealth Group (NYSE: UNH) are falling today, down 4.5% as of 2:41 p.m. ET. The drop comes as the S&P 500 (SNPINDEX: ^GSPC) gained 0.3% and the Nasdaq Composite (NASDAQINDEX: ^IXIC) gained 0.8%. The troubled health insurance giant is seeing its stock slide after a fellow insurer announced it was pulling its full-year guidance. Centene, a rival insurer, announced late Tuesday that it is pulling its previously set earnings and revenue guidance for 2025. The company said that new data from its Affordable Care Act plans was so poor that it would need to readjust. Centene said that preliminary data indicated it will need to cut its previous 2025 earnings per share (EPS) target of $7.25 by $2.75 per share. Mizuho analyst Ann Hynes told investors this morning she believes it could be cut by as much as half. The massive downward adjustment is the latest in a string of bad news for the insurance industry, leading to stocks slipping across the board. The company is under investigation by the DOJ for fraudulent billing practices in its Medicare division, and a recent investigative report by The Guardian revealed that UnitedHealth has been making secret bonus payments to nursing homes in order to keep ailing residents out of hospitals and save money. The report also claims the company staffed nursing homes with its own medical teams who, at times, interfered in order to keep residents who needed hospital care from receiving it. There are just too many issues facing UnitedHealth at the moment, with no clear picture of an imminent turnaround. This once-seemingly stable investment looks far from it at the moment, and I would stay away from the stock. Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $697,627!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $939,655!* Now, it's worth noting Stock Advisor's total average return is 1,045% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Johnny Rice has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. Why UnitedHealth Stock Is Sinking Again Today was originally published by The Motley Fool Sign in to access your portfolio